Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Getting Breakthrough Biotechnologies To Market
Biotechnology moves quickly, and successful innovation depends on more than breakthrough science. Learn how adaptable strategies can help teams connect emerging tools and manage uncertainty.
-
Therapeutic Peptides: Challenges And Solutions For Drug Developers
Therapeutic peptide manufacturing depends on more than synthesis. Discover approaches for verifying raw materials, detecting difficult impurities, and confirming complex sequences with confidence.
-
Ushering In A New Era Of Human-Relevant Drug Discovery
With most drug candidates failing before approval, researchers need better ways to predict human responses. Gain insight into how advances in human-relevant modeling are helping improve decisions.
-
How Organ-Chips Are Transforming Women's Reproductive Health Research
Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.
-
Target Product Profile (TPP) Explained
Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Evaluating Clone Performance And Cell-Specific Productivity
See how continuous process monitoring and automated at-line analytics support confident CHO clone ranking, consistent cultivation, and scale-up by connecting pH, viable cell density, and more.
-
A Comparison To Traditional Clone Screening Platforms
See how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
Characterizing mRNA Using Ion-Pairing Reversed-Phase LC/MS
mRNA poly(A) tail analysis depends on targeted digestion, clean LC/MS conditions, and reliable deconvolution. See how RNase 4 digestion and optimized ion-pairing methods support reproducible results.
-
Effect Of Column Chemistry On The Separation Of GLP-1 Peptides
Small changes in mobile phase, temperature, and column chemistry can affect the detection of GLP-1 peptide impurities. Learn which conditions improve resolution for challenging peptide analyses.
FORMULATION DEVELOPMENT SOLUTIONS
- Where Expertise Meets Simplicity: BD PartnerPath™ Program
- Comprehensive ADC And Bioconjugation Services For Targeted Therapies
- Drug Product Development And Manufacturing Services
- Drug-Drug Interaction (DDI) Studies
- Curia R&D Pipeline Overview
- Potent, Selective Modulators Of Protein Functions
- Continuous Flow
- ACQUITY Premier Analytical Solution
- Inhaled Product Development
- Drive Your Performance Forward With The Expanded Family Of Efficient-Pro Feeds
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- STERIS To Invest $600 Million To Build Center Of Excellence In North Carolina
- BeOne Committing $1 Billion+ To U.S. Drug Manufacturing Growth
- Why GSK Is Investing £400 Million In Cambridge
- Virtual Pharma Expo Launches Searchable Six-Year Equipment Demo Archive Ahead Of September Solid Dosage Event
- ROSS 250-Gallon Retention Mixers Designed For High-Pressure Processing
- New Carrying Straps Simplify Handling Of Meissner's 16 L CryoVault® Container
- Natoli Engineering Announces Acquisition Of Scheu & Kniss
- Esco Lifesciences To Showcase Innovative Laboratory And Pharmaceutical Solutions At ISPE Singapore Conference & Exhibition 2026
- Amneal's Planned Sterile Facility Creates Opportunity For Aseptic Filling, Isolator, And Automation Suppliers
- Lonza Expands HPAPI Capacity In Visp, Further Supporting Its Position In Payload-Linker Manufacturing